FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998796661> ?p ?o ?g. }

• W1998796661 endingPage "500" @default.
• W1998796661 startingPage "494" @default.
• W1998796661 abstract "Abstract Objective To investigate the different characteristics in Chinese Han women with polycystic ovary syndrome, and to analyze the significance of hyperandrogenism in insulin resistance and other metabolic profiles. Design A cross‐sectional study. Setting Medical university hospital. Population A total of 229 women with polycystic ovary syndrome aged 18–45 years. Methods Women with polycystic ovary syndrome, diagnosed by Rotterdam criteria, were divided into four groups according to the quartile intervals of free androgen index levels. Main outcome measures Comparisons between groups were performed using one‐way analysis of variance. Stepwise logistic regression analysis was performed to investigate the association between homeostasis model assessment‐insulin resistance and independent variables. Results Within the four phenotypes, women with phenotype 1 (hyperandrogenism, oligo/anovulation, and polycystic ovaries) exhibited higher total testosterone, free androgen index, androstenedione, low‐density lipoprotein, and lower quantitative insulin sensitivity check index ( p < 0.05); women with phenotype 4 (oligo/anovulation and polycystic ovaries) showed lower total cholesterol, low‐density lipoprotein, and homeostasis model assessment‐insulin resistance, but higher high‐density lipoprotein ( p < 0.05). The levels of triglycerides, total cholesterol, low‐density lipoprotein, and homeostasis model assessment‐insulin resistance significantly increased, but high‐density lipoprotein and quantitative insulin sensitivity check index decreased with the elevation of free androgen index intervals. After adjustment for lipid profiles, free androgen index was significantly associated with homeostasis model assessment‐insulin resistance in both lean and overweight/obese women (odds ratio 1.302, p = 0.039 in lean vs. odds ratio 1.132, p = 0.036 in overweight/obese). Conclusions Phenotypes 1 and 4 represent groups with the most and least severe metabolic profiles, respectively. Hyperandrogenism, particularly with elevated free androgen index, is likely a key contributing factor for insulin resistance and for the aggravation of other metabolic profiles." @default.
• W1998796661 created "2016-06-24" @default.
• W1998796661 creator A5001304653 @default.
• W1998796661 creator A5052342599 @default.
• W1998796661 creator A5071037763 @default.
• W1998796661 creator A5081773758 @default.
• W1998796661 creator A5088094052 @default.
• W1998796661 creator A5091702178 @default.
• W1998796661 date "2015-03-19" @default.
• W1998796661 modified "2023-09-27" @default.
• W1998796661 title "Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome" @default.
• W1998796661 cites W1538946743 @default.
• W1998796661 cites W1969169362 @default.
• W1998796661 cites W1984067141 @default.
• W1998796661 cites W1984323756 @default.
• W1998796661 cites W2035217519 @default.
• W1998796661 cites W2044970382 @default.
• W1998796661 cites W2047021937 @default.
• W1998796661 cites W2048018726 @default.
• W1998796661 cites W2050593976 @default.
• W1998796661 cites W2065545834 @default.
• W1998796661 cites W2069178927 @default.
• W1998796661 cites W2086102771 @default.
• W1998796661 cites W2096887626 @default.
• W1998796661 cites W2101007245 @default.
• W1998796661 cites W2104763965 @default.
• W1998796661 cites W2117559317 @default.
• W1998796661 cites W2129451889 @default.
• W1998796661 cites W2133103099 @default.
• W1998796661 cites W2142532131 @default.
• W1998796661 cites W2158906537 @default.
• W1998796661 cites W2159046809 @default.
• W1998796661 cites W2163069137 @default.
• W1998796661 cites W2168771527 @default.
• W1998796661 cites W2186218348 @default.
• W1998796661 cites W2324024668 @default.
• W1998796661 cites W4253220051 @default.
• W1998796661 doi "https://doi.org/10.1111/aogs.12612" @default.
• W1998796661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25711494" @default.
• W1998796661 hasPublicationYear "2015" @default.
• W1998796661 type Work @default.
• W1998796661 sameAs 1998796661 @default.
• W1998796661 citedByCount "21" @default.
• W1998796661 countsByYear W19987966612015 @default.
• W1998796661 countsByYear W19987966612016 @default.
• W1998796661 countsByYear W19987966612017 @default.
• W1998796661 countsByYear W19987966612018 @default.
• W1998796661 countsByYear W19987966612019 @default.
• W1998796661 countsByYear W19987966612020 @default.
• W1998796661 countsByYear W19987966612021 @default.
• W1998796661 countsByYear W19987966612022 @default.
• W1998796661 countsByYear W19987966612023 @default.
• W1998796661 crossrefType "journal-article" @default.
• W1998796661 hasAuthorship W1998796661A5001304653 @default.
• W1998796661 hasAuthorship W1998796661A5052342599 @default.
• W1998796661 hasAuthorship W1998796661A5071037763 @default.
• W1998796661 hasAuthorship W1998796661A5081773758 @default.
• W1998796661 hasAuthorship W1998796661A5088094052 @default.
• W1998796661 hasAuthorship W1998796661A5091702178 @default.
• W1998796661 hasBestOaLocation W19987966611 @default.
• W1998796661 hasConcept C126322002 @default.
• W1998796661 hasConcept C134018914 @default.
• W1998796661 hasConcept C2776405666 @default.
• W1998796661 hasConcept C2777391703 @default.
• W1998796661 hasConcept C2777911890 @default.
• W1998796661 hasConcept C2778535154 @default.
• W1998796661 hasConcept C2778901321 @default.
• W1998796661 hasConcept C2779279991 @default.
• W1998796661 hasConcept C2779306644 @default.
• W1998796661 hasConcept C2780186808 @default.
• W1998796661 hasConcept C2780853582 @default.
• W1998796661 hasConcept C3017594256 @default.
• W1998796661 hasConcept C3018442814 @default.
• W1998796661 hasConcept C3018667095 @default.
• W1998796661 hasConcept C71315377 @default.
• W1998796661 hasConcept C71924100 @default.
• W1998796661 hasConceptScore W1998796661C126322002 @default.
• W1998796661 hasConceptScore W1998796661C134018914 @default.
• W1998796661 hasConceptScore W1998796661C2776405666 @default.
• W1998796661 hasConceptScore W1998796661C2777391703 @default.
• W1998796661 hasConceptScore W1998796661C2777911890 @default.
• W1998796661 hasConceptScore W1998796661C2778535154 @default.
• W1998796661 hasConceptScore W1998796661C2778901321 @default.
• W1998796661 hasConceptScore W1998796661C2779279991 @default.
• W1998796661 hasConceptScore W1998796661C2779306644 @default.
• W1998796661 hasConceptScore W1998796661C2780186808 @default.
• W1998796661 hasConceptScore W1998796661C2780853582 @default.
• W1998796661 hasConceptScore W1998796661C3017594256 @default.
• W1998796661 hasConceptScore W1998796661C3018442814 @default.
• W1998796661 hasConceptScore W1998796661C3018667095 @default.
• W1998796661 hasConceptScore W1998796661C71315377 @default.
• W1998796661 hasConceptScore W1998796661C71924100 @default.
• W1998796661 hasFunder F4320321001 @default.
• W1998796661 hasIssue "5" @default.
• W1998796661 hasLocation W19987966611 @default.
• W1998796661 hasLocation W19987966612 @default.
• W1998796661 hasOpenAccess W1998796661 @default.
• W1998796661 hasPrimaryLocation W19987966611 @default.

• next